title: A programmed release multi-drug implant fabricated by three-dimensional printing technology for bone tuberculosis therapy.
abstract: In the world, bone tuberculosis is still very difficult to treat and presents a challenge to clinicians. In this study, we utilized 3D printing technology to fabricate a programmed release multi-drug implant for bone tuberculosis therapy. The construction of the drug implant was a multi-layered concentric cylinder divided into four layers from the center to the periphery. Isoniazid and rifampicin were distributed individually into the different layers in a specific sequence of isoniazid-rifampicin-isoniazid-rifampicin. The drug release assays in vitro and in vivo showed that isoniazid and rifampicin were released orderly from the outside to the center to form the multi-drug therapeutic alliance, and the peak concentrations of drugs were detected in sequence at 8 to 12 day intervals. In addition, no negative effect on the proliferation of rabbit bone marrow mesenchymal stem cells was detected during the cytocompatibility assay. Due to its ideal pharmacologic action and cytocompatibility, the programmed release multi-drug implant with a complex construction fabricated by 3D printing technology could be of interest in prevention and treatment of bone tuberculosis.
authors.affiliation: Department of Orthopaedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, People's Republic of China.
authors.forename: Weigang
authors.initials: W
authors.lastname: Wu
authors.forename: Qixin
authors.initials: Q
authors.lastname: Zheng
authors.forename: Xiaodong
authors.initials: X
authors.lastname: Guo
authors.forename: Jianhua
authors.initials: J
authors.lastname: Sun
authors.forename: Yudong
authors.initials: Y
authors.lastname: Liu
mesh_terms: D000818:Animals; D000995:Antitubercular Agents / Q000494:pharmacology; D049109:Cell Proliferation; D016503:Drug Delivery Systems; D004343:Drug Implants / Q000494:pharmacology*; D004867:Equipment Design; D007538:Isoniazid / Q000494:pharmacology; D008297:Male; D059630:Mesenchymal Stem Cells / Q000166:cytology*; D008858:Microscopy, Phase-Contrast / Q000379:methods; D011208:Powders; D011817:Rabbits; D012293:Rifampin / Q000494:pharmacology; D014394:Tuberculosis, Osteoarticular / Q000188:drug therapy*
chemical_list: D000995:Antitubercular Agents; D004343:Drug Implants; D011208:Powders; D007538:Isoniazid; D012293:Rifampin